Status Epilepticus Flashcards
ILAE definition of status epilepticus:
SE is a condition resulting either from:
- failure of the mechanism responsible for seizure termination
- the initiation of mechanisms which leads to abnormally prolonged seizures
(after time point t1)
SE is a condition that can have long-term consequences including:
- neuronal death
- neuronal injury
- alteration of neuronal networks
- functional deficits
(after time point t2)
SE
- Homeostatic mechanism
Homeostatic mechanism is lost, and glutamate is released in massive amounts
- Calcium influx
- Release of neurotransmitters
- Excess depolarization
Also unable to increase blood flow to the brain
- Vital signs: BP, HR etc.
- Result in hypoxia, thus require oxygenation
- Result in hypoglycemia
Tonic-clonic status epilepticus
- What are the time points T1 and T2, and what are the implications?
T1: 5min
- Indicates the time that emergency treatment should be started as seizure is likely to be prolonged leading to continuous seizure activity
T2: 30min
- Indicates the time at which long-term consequences may be expected (neuronal death, neuronal injury, alteration of neuronal networks, functional deficits)
What are the four phases of SE treatment?
- Stabilization phase (0-5min)
- Initial therapy phase (5-20min)
- Second therapy phase (20-40min)
- Third therapy phase (40-60min)
Stabilization phase (0-5min)
- Stabilize patient (breathing, circulation, disability)
- Monitor vital signs
- Assess oxygenation
- Initiate ECG monitoring
- Collect finger stick blood glucose, ensure no hypoglycemia (treat with thiamine, dextrose if glucose <60mg/dl)
- Attempt IV access and collect electrolytes, hematology toxicology screen
Initial therapy phase (5-20min)
- Given seizure continued past 5min
First line: Benzodiazepine
- IM Midazolam (SA) - single dose
- IV Lorazepam (IA) - may repeat dose once
- IV Diazepam (LA) - may repeat dose once
If BZD not available,
- IV Phenobarbital - single dose
- Rectal Diazepam - single dose
- Intranasal/Buccal Midazolam
Second therapy phase (20-40min)
No evidence-based preferred for second therapy of choice
Single dose of one of the following:
- IV Phenytoin
- IV Valproic acid
- IV Levetiracetam
(among the agents, may add on as well)
If none available,
- IV Phenobarbital
Third therapy phase (40-60min)
No clear evidence to guide therapy
- May repeat second line therapy
- May try anesthetic doses of thiopental, midazolam, pentobarbital, or propofol (all with continuous EEG monitoring)